Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review.

MLA

Yao, Yifang, et al. “Efficacy and Safety of Thrombopoietin Receptor Agonists in the Treatment of Thrombocytopenia after Hematopoietic Stem Cell Transplantation: A Meta-Analysis and Systematic Review.” Expert Review of Hematology, vol. 14, no. 11, Nov. 2021, pp. 1041–48. EBSCOhost, https://doi.org/10.1080/17474086.2021.2009337.

APA

Yao, Y., Tang, Y., Qi, J., Li, X., Zhang, R., Xu, X., Pan, T., & Han, Y. (2021). Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review. Expert Review of Hematology, 14(11), 1041–1048. https://doi.org/10.1080/17474086.2021.2009337

Chicago

Yao, Yifang, Yaqiong Tang, JiaQian Qi, Xueqian Li, Rui Zhang, Xiaoyan Xu, Tingting Pan, and Yue Han. 2021. “Efficacy and Safety of Thrombopoietin Receptor Agonists in the Treatment of Thrombocytopenia after Hematopoietic Stem Cell Transplantation: A Meta-Analysis and Systematic Review.” Expert Review of Hematology 14 (11): 1041–48. doi:10.1080/17474086.2021.2009337.